We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.
- Authors
Cooper, David A; Heera, Jayvant; Goodrich, James; Tawadrous, Margaret; Saag, Michael; Dejesus, Edwin; Clumeck, Nathan; Walmsley, Sharon; Ting, Naitee; Coakley, Eoin; Reeves, Jacqueline D; Reyes-Teran, Gustavo; Westby, Mike; Van Der Ryst, Elna; Ive, Prudence; Mohapi, Lerato; Mingrone, Horacio; Horban, Andrzej; Hackman, Frances; Sullivan, John; Mayer, Howard
- Abstract
The MERIT (Maraviroc versus Efavirenz in Treatment-Naive Patients) study compared maraviroc and efavirenz, both with zidovudine-lamivudine, in antiretroviral-naive patients with R5 human immunodeficiency virus type 1 (HIV-1) infection.
- Publication
The Journal of infectious diseases, 2010, Vol 201, Issue 6, p803
- ISSN
1537-6613
- Publication type
Journal Article
- DOI
10.1086/650697